About Us

What does DAHW stand for?
DAHW stands for German Leprosy and Tuberculosis Aid (DAHW) and is a non governmental organization that has been working in close cooperation with national health authorities in Asia, Africa and South America to combat leprosy, tuberculosis and neglected tropical diseases since 1957. It also carries out humanitarian assistance, rehabilitation and social inclusion measures for people with disabilities and marginalized and vulnerable groups.
How do we work?
With direct operations or through local partners, DAHW develops various projects aimed at: improving the knowledge of health workers, the active search for cases, diagnosis, and timely treatment of Leprosy, Tuberculosis, and neglected tropical diseases in endemic areas of the countries. It conducts educational workshops with people affected by these pathologies and supports their comprehensive rehabilitation. It develops information, education, and communication activities for community groups that are more vulnerable to these diseases, and distributes educational resources. DAHW has supported medical and social assistance programs in Latin America since 1967. It began its cooperation in Bolivia, supporting the national leprosy program, and later extended its assistance to Brazil, Colombia, Paraguay, Ecuador, and Argentina.
It currently supports projects for the control of Neglected Tropical Diseases (NTDs), Leprosy, and projects aimed at the rehabilitation of people with disabilities and vulnerable groups in Bolivia, Brazil, Colombia, and Paraguay.
Source accessed at https://www.dahwsuramerica.org/es/ on August 24, 2022


Why focus on leprosy?
It is a disease of low contagiousness, not inheritable, effectively curable with a treatment consisting of several drugs whose duration ranges from six to twelve months. Its early treatment prevents disability. Leprosy has been a disease stigmatized by society and throughout human history, continues to be accompanied by ignorance, fear, myths, and superstitions that often reduce the possibility of early diagnosis and effective treatment. That is why it is considered one of the primary causes of disability and mutilation.
According to estimates, 25% of patients who are not detected and treated early develop insensitivity and even severe deformities of the hands and feet, which become a serious disadvantage in daily life. The disease itself does not limit the patient’s ability to work; it is the stigma and social discrimination that make it more difficult for people affected by the disease to continue their usual tasks and lead a completely normal life. Disabilities caused by late diagnosis are the only cause of physical, psychological, and occupational limitations, which, if not corrected in time, can lead these people to marginalization and social exclusion.
Source of reference: https://www.dahwsuramerica.org/es/nuestro-enfoque/lepra/ on August 24, 2022
